Back to search results
NCT06657001

Enabling Microbiomics- Driven Personalized Nutrition

Enrolling by Invitation
Not specifiedAges 18+Observational
Mayo Clinic
~4,001 participants
Updated 2026-06-12 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To Correlate Differences in Diet and Microbiome with Different GI Symptoms and Disease States
Measured over From enrollment through study completion, an average of 1 year.

Conditions

Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Celiac Disease
Diarrhea
Constipation
Microbiome
Crohn's Disease
UC - Ulcerative Colitis
Microscopic Colitis
Functional Dyspepsia

Explore related trials

Celiac DiseaseConstipationCrohn DiseaseDiarrheaDigestive System DisorderHealthy VolunteersInflammatory Bowel DiseaseIrritable Bowel SyndromeMicroscopic ColitisNonulcer dyspepsiaUlcerative Colitis

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Purna Kashyap, MBBS · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age greater than or equal to 18 years
Gastrointestinal patients with or without genomic sequencing results available for the following cohorts:
Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Crohn's Disease
Celiac Disease
Diarrhea
Constipation
Healthy age and sex matched controls with or without genomic sequencing results available
Able to provide written, informed consent
Participant has a smartphone device with access to internet connection

Exclusion

Patients with cognitive impairment
Active use of antibiotics at the time of stool collection

What this trial measures

  • To Correlate Differences in Diet and Microbiome with Different GI Symptoms and Disease StatesFrom enrollment through study completion, an average of 1 year.

    Investigators will prospectively follow the clinical course of the patients throughout the duration of the study. Patient health outcomes will be documented from their medical record while the study is actively enrolling or undergoing data analysis.